# Clinical Practice of AECOPD Management in China

> **NCT02051166** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5095 (actual)

## Conditions studied

- Acute Exacerbation of Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02051166
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 5095 (ACTUAL)
- **Last updated:** 2016-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051166, "Clinical Practice of AECOPD Management in China". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02051166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*